EDAP TMS S.A. (FOCL) vs Precision Optics (POCI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
EDAP TMS S.A. (FOCL) has outperformed Precision Optics (POCI) over the past year, gaining 13.5% versus a loss of 10.4%. Over five years, POCI leads with a -37.9% price change compared with -53.0% for FOCL. EDAP TMS S.A. is the larger company by market cap ($123.2 million vs $45.3 million), about 2.7 times the size, while Precision Optics is growing revenue faster (+65.2% vs +1.6%).
Precision Optics converts more of its revenue into profit, with a net margin of -11.5% versus -41.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FOCL | POCI |
|---|---|---|
| Share price | $2.61 | $4.12 |
| Market cap | $123.25M | $45.30M |
| 1-day change | -7.45% | +1.41% |
| YTD return | -20.67% | -1.67% |
| 1-year return | +13.48% | -10.43% |
| 5-year return | -52.97% | -37.86% |
| Forward P/E | — | 206.00 |
| EPS (TTM) | $-1.35 | $-0.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $70.53M | $31.53M |
| Revenue growth (YoY) | +1.63% | +65.16% |
| Net income (latest FY) | $-29.25M | $-3.63M |
| Gross margin | 42.54% | 17.22% |
| Operating margin | -35.01% | -11.13% |
| Net margin | -41.47% | -11.51% |
| 52-week high | $6.40 | $6.15 |
| 52-week low | $2.11 | $3.55 |
| Distance from 52-week high | -59.22% | -33.01% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +218.01% | +94.17% |
| Average volume | 137.30K | 43.00K |
| Shares outstanding | 47.22M | 10.99M |
| Employees | 289 | 108 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EDAP TMS S.A. is about 2.7 times larger than Precision Optics by market value ($123.25M vs $45.30M).
- FOCL has outperformed POCI by 23.9 percentage points over the past year.
- Precision Optics is more profitable, keeping -11.5 cents of every revenue dollar as net income versus -41.5 cents for EDAP TMS S.A..
- Precision Optics grew revenue faster in its latest fiscal year (+65.16% vs +1.63%).
About EDAP TMS S.A.
FOCL stock →EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 289 employees
About Precision Optics
POCI stock →Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 108 employees
FOCL vs POCI FAQ
Which is bigger, EDAP TMS S.A. or Precision Optics?
EDAP TMS S.A. (FOCL) is larger, with a market capitalization of $123.25M compared with $45.30M for Precision Optics (POCI).
Which stock has performed better over the past year, FOCL or POCI?
FOCL returned +13.48% over the past 12 months, compared with -10.43% for POCI (price return, excluding dividends). Past performance does not predict future results.
Are EDAP TMS S.A. and Precision Optics in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.